Skip to main content
2026 CRT Conference Main banner

CRT 2026

Power Break Symposium

Session:: Power Break Symposium | Innovative Solutions for Coronary Thrombus & the Treatment of Pulmonary Embolism [Non-CME] – Sponsored by Penumbra

Q&A

Sunday, March 8, 2026
1:16 PM - 1:30 PM EST
Location: International Ballroom East

    Panel Discussant(s)

  • George Chrysant, MD

    Chief Medical Officer
    INTEGRIS Cardiovascular Physicians, LLC
    Oklahoma City, Oklahoma, United States

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Acarix: Chief Medical Advisor (Ongoing); philips,shockwave,penumbra: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Suhail Dohad, MD

    Medical director of aortic and ischemic limb disease. Director of complex PCI/Endovascular fellowship
    Cedars Sinai Medical Center
    Beverly Hills, California, United States

    Disclosure(s): No financial relationships to disclose

  • S. Jay Mathews, MD

    Director, Cardiac Cath Lab, PERT, & Structural Heart
    Manatee Memorial Hospital

    Disclosure(s): Abiomed: Grant/Research Support (Ongoing); Akura: Grant/Research Support (Ongoing), Stock Options [in privately held companies] (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cagent Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Gore: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Innova vascular: Grant/Research Support (Ongoing), Stock Options [in privately held companies] (Ongoing); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Protexa: Stock Options [in privately held companies] (Ongoing); R3: Grant/Research Support (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), Stock Options [in privately held companies] (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):
George Chrysant, MD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Acarix: Chief Medical Advisor (Ongoing); philips,shockwave,penumbra: Consulting Fees (e.g., advisory boards) (Ongoing)
Suhail Dohad, MD: No financial relationships to disclose
S. Jay Mathews, MD: Abiomed: Grant/Research Support (Ongoing); Akura: Grant/Research Support (Ongoing), Stock Options [in privately held companies] (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cagent Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Gore: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Innova vascular: Grant/Research Support (Ongoing), Stock Options [in privately held companies] (Ongoing); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Protexa: Stock Options [in privately held companies] (Ongoing); R3: Grant/Research Support (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), Stock Options [in privately held companies] (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)